0001179110-14-018715.txt : 20141224 0001179110-14-018715.hdr.sgml : 20141224 20141224125849 ACCESSION NUMBER: 0001179110-14-018715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141222 FILED AS OF DATE: 20141224 DATE AS OF CHANGE: 20141224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cogan John Francis CENTRAL INDEX KEY: 0001319872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 141309646 MAIL ADDRESS: STREET 1: 2010 NORTH FIRST STREET, SUITE 310 CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 edgar.xml FORM 4 - X0306 4 2014-12-22 0 0000882095 GILEAD SCIENCES INC GILD 0001319872 Cogan John Francis 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 0 0 0 Common Stock 2014-12-22 4 M 0 26000 14.3375 A 68405 D Common Stock 2014-12-22 4 S 0 5650 93.1762 D 62755 D Common Stock 2014-12-22 4 S 0 5322 94.1255 D 57433 D Common Stock 2014-12-22 4 S 0 5071 94.9663 D 52362 D Common Stock 2014-12-22 4 S 0 6400 96.2784 D 45962 D Common Stock 2014-12-22 4 S 0 3240 97.0923 D 42722 D Common Stock 2014-12-22 4 S 0 317 97.9136 D 42405 D Non-Qualified Stock Option (Right to Buy) 14.3375 2014-12-22 4 M 0 26000 0 D 2016-05-10 Common Stock 26000 0 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Options are 100% vested on the date of grant. Sale prices reported for the transactions reported here range from $92.60 to $93.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $93.65 to $94.61. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $94.66 to $95.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $95.69 to $96.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $96.69 to $97.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $97.91 to $97.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ John F. Milligan by Power of Attorney for John F. Cogan 2014-12-24